|
|
||||||||
Eur J Cardiothorac Surg 2000;17:747-751
© 2000 Elsevier Science NL
a Department of Cardiac Surgery, Papworth Hospital, Papworth Everard, Cambridge CB3 8RE, UK
b Department of Pathology, Papworth Hospital, Papworth Everard, Cambridge CB3 8RE, UK
Corresponding author. Tel.: +44-1480-830-541; fax: +44-1480-364-338
e-mail: goodwinat{at}hotmail.com
| Abstract |
|---|
|
|
|---|
Key Words: Post-mortem Cardiac surgery Outcome Audit Risk stratification
| 1. Introduction |
|---|
|
|
|---|
We present a study in which the post-mortem rate is high. We aimed to compare presumed versus actual cause of death. In addition, we wished to see whether any pre-operative risk factors correlated with the eventual cause of death.
| 2. Methods |
|---|
|
|
|---|
The post-mortem request forms were analyzed to obtain the presumed clinical cause of death. The post-mortem and clinical cause of death were compared. Multiple pre-operative variables for each patient were obtained from a hospital database recorded at the time of surgery. The variables collected included age, sex, operation, previous cardiac surgery, left ventricular function, diabetes, hypertension, pre-existing renal failure, body mass index, urgency of operation, pre-operative intra-aortic balloon use and various catastrophic states. This allowed risk stratification according to the system devised by Parsonnet for each patient [6,7]. In addition data were collected on pre-operative creatinine and atrial fibrillation.
At post-mortem evidence was sought to confirm the presence of the disease being operated on (e.g. coronary atheroma, evidence of ventricular hypertrophy/distension in valve patients). In addition, evidence was sought of surgical misadventure. Following this the cause of death is established and whether or not it is related to the heart. In the absence of any other demonstrable abnormality it is assumed that the cause of death is due to the underlying cardiac problem which led to the operation being performed. Histological examination was performed in all patients. Each patient underwent standard sampling of the coronaries and myocardium as well as any other relevant organs.
Data were 100% complete for both post-mortem and risk data. Results are expressed as mean±SEM. Data were compared using a chi-square test or MannWhitney test as appropriate.
| 3. Results |
|---|
|
|
|---|
|
|
|
|
When cardiac deaths were compared with non-cardiac causes, the Parsonnet score was higher: 20.0±1.4 vs. 15.2±1.6, P=0.07; and greater proportion tended to have poor ejection fractions (34 vs. 15%), P=0.12. There was no significant difference between the cardiac and non-cardiac groups in terms of age, sex, operation, hypertension, diabetes, body mass index, creatinine and pre-operative atrial fibrillation (Table 5).
|
| 4. Discussion |
|---|
|
|
|---|
It has been suggested that modern diagnostic techniques leave the cause of death in much less doubt [4,5]. Post-mortem analysis, however, remains the gold standard and final arbiter. The major advantage of post-mortem over other tests is that it allows the sampling of tissues for histological examination. This can be particularly useful in determining myocardial infarction, small pulmonary emboli and adult respiratory distress syndrome, as well as many other histological diagnoses. There are other potential benefits in the collection of such information, such as the utilization of histological tissue for research and study. Also, in order for progress to be made, the information available to clinicians from post-mortems is invaluable [5,9,10]. Such information underpins the activity of clinical audit where the basic presumption is of accurate information. If the outcome data in any study are inaccurate then any information derived from them remains flawed.
Our findings differ from previously published series in number of ways (Table 6). Our post-mortem rate is high (84%) compared with the series by Zehr et al. (24%) but similar to that of Lee et al. (88%) [2,3]. The most striking difference is in the proportion of deaths due to cardiac causes, 68 vs. 27%, in the American paper. This may be because the post-mortem rate is low and different diagnostic criteria may exist in the different patient populations. In addition, the proportion of deaths of unknown cause in the United States series is 25% whereas in this series there were none. In patients within our series where there was little to find at post-mortem, such as following a sudden or arrhythmic death, the cause has been attributed to the underlying cardiac condition for which the operation was performed. The other major difference between this series and others is the high proportion of deaths due to gastrointestinal causes (10 vs. 3 and 1%). This may also be due to different populations of patients undergoing different operations. For example, there were 53% of patients undergoing CABG in our series compared with 32 and 34% in the other published series [2,3]. In addition, the series by Zehr et al. includes transplant and aortic surgery. Other possible differences between the institutions may include differences in intra-operative technique (such as bypass perfusion pressures and systemic hypothermia) and post-operative management (such as inotrope usage and drug therapy). There were no significant differences in the pre-operative risk factors and operations performed in the patients dying of gastrointestinal causes (Tables 4 and 5).
|
In conclusion, post-mortem can identify undiagnosed causes of death in a significant proportion of patients following cardiac surgery. In addition, the risk factors utilized to determine risk stratification correlate poorly with the actual cause of death. Post-mortem information remains the gold standard outcome measure which underpins the improvements in clinical standards we all seek.
| Footnotes |
|---|
| Appendix A Conference discussion |
|---|
|
|
|---|
Mr Goodwin: How often did the post-mortem not show an answer? Is that what are you asking?
Dr Irarrazaval: Yes, because sometimes, particularly in the acute situation, the patient dies and you are not sure what was the reason. How often did the path study not show a clear answer?
Mr Goodwin: In some of the cardiac cases it can be very difficult to give a definite cause of death; however, in the absence of other pathologies, then a cardiac cause was given by the pathologist, having searched thoroughly for other causes.
Dr Irarrazaval: A lot of these patients have several causes, for instance, multiple organ failure or sepsis very frequently started with something like cardiac or respiratory failure. How did you handle that to assign the responsibility?
Mr Goodwin: If at post-mortem it was found to be due to multi-organ failure, then the death was assigned to that. If there was nothing else found and there were cardiac causes underlying it then it was assigned as a cardiac death.
Dr B. Buxton (Victoria, Australia): As you have indicated in your post-mortem study, we are always going to have trouble predicting patient-specific outcome as opposed to group predictions. The problem is that we have these isolated events in the patient-specific category, for example calcified aortas, liver transplantations and gastrointestinal complications which don't show up in group data but are very highly specific to patient outcome. You have brought this issue to our attention very clearly. It is essentially quite difficult to improve patient-specific prediction. We use estimates of outcome derived from group data and build on top of that a second tier of predictors which are then applied to an individual patient.
Mr Goodwin: I think one of the reasons for performing this study is perhaps because individual patients are being refused surgery on the basis of risk scoring systems which assign them as being high risk, whereas you cannot actually tell for any individual patient. Obviously there is clinical suspicion, and with a large population you can predict outcome. It doesn't seem particularly fair for one individual patient sitting in a clinic to refuse them an operation just on the basis of an overall risk scoring system.
Dr Buxton: It is very difficult to define the importance of specific patient predictors. For example, what is the risk of a calcified aorta? It is high, but we don't have enough patients with calcified aortas to to know exactly what the probability of death is, nor can we stratify those small groups. You have illustrated some of the major problems in patient-specific prediction.
Dr B. Messmer (Aachen, Germany): To go back to the first question about cardiac death or death of unknown reasons, most people are a little bit reluctant to do a post-mortem because often you don't see anything, and then you assume it's cardiac. Of course the patient dies finally because the heart stops. But in the very early phase the pathologist almost never can give you an exact cardiac cause. It takes a certain time, and that is one of the crucial points. Regarding your unexpected deaths due to intestinal complications, did you draw any conclusions from your results? We are pretty liberal by doing explorative laparotomy especially when the lactate level goes up and the patient has abdominal symptoms. In such cases mesenteric infarction or scattered bleeding is often found. If you don't do anything such a patient will die. Therefore again I ask my question: Did you draw any conclusions from your results?
Mr Goodwin: Yes. The surprising finding of this study was the high level of gastrointestinal complications, and we have subsequently gone back and re-reviewed the patients ITU charts, looking for whether there was anything which we could perhaps have detected prior to death. The commonest finding was, as you suggested, the lactic acidosis or metabolic acidosis with no other explanation. And certainly we have a much more liberal policy with either laparotomy, or even a diagnostic laparoscopy, looking for gastrointestinal problems in patients with unexplained metabolic acidosis.
Dr J. Pirk (Prague, Czech Republic): Well, I would suggest you should go further. You should examine these patients before the surgery, maybe for Helicobacter, or whatever. After surgery it is too late.
Mr Goodwin: Thank you.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
D. L. Ngaage, M. E. Cowen, and A. R. Cale Cardiopulmonary bypass and left ventricular systolic dysfunction impacts operative mortality differently in elderly and young patients Eur. J. Cardiothorac. Surg., February 1, 2009; 35(2): 235 - 240. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. K. Stoller, E. Blackstone, G. Pettersson, and T. Mihaljevic Coronary Artery Bypass Graft and/or Valvular Operations Following Prior Pneumonectomy: Report of Four New Patients and Review of the Literature Chest, July 1, 2007; 132(1): 295 - 301. [Abstract] [Full Text] [PDF] |
||||
![]() |
M F Hickling, D E Pontefract, P J Gallagher, and S A Livesey Post mortem examinations after cardiac surgery Heart, June 1, 2007; 93(6): 761 - 765. [Full Text] [PDF] |
||||
![]() |
A. J. Rastan, J. F. Gummert, N. Lachmann, T. Walther, D. V. Schmitt, V. Falk, N. Doll, P. Caffier, M. M. Richter, C. Wittekind, et al. Significant value of autopsy for quality management in cardiac surgery J. Thorac. Cardiovasc. Surg., June 1, 2005; 129(6): 1292 - 1300. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Weissman Pulmonary Complications After Cardiac Surgery Seminars in Cardiothoracic and Vascular Anesthesia, September 1, 2004; 8(3): 185 - 211. [Abstract] [PDF] |
||||
![]() |
A. Ooi, A. T. Goodwin, M. Goddard, and A. J. Ritchie Clinical outcome versus post-mortem finding in thoracic surgery: a 10-year experience Eur. J. Cardiothorac. Surg., June 1, 2003; 23(6): 878 - 882. [Abstract] [Full Text] [PDF] |
||||
![]() |
R.V. Venkateswaran, S.C. Charman, M. Goddard, and S.R. Large Lethal mesenteric ischaemia after cardiopulmonary bypass: a common complication? Eur. J. Cardiothorac. Surg., October 1, 2002; 22(4): 534 - 538. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |